MegaSporeBiotic™ probiotic

MegaSporeBiotic™ is a probiotic containing 100% viable bacterial endospores with a broad spectrum of activity and clinically proven effectiveness in maintaining the proper functioning of the intestinal barrier.

What are the benefits?

  • reduction in inflammation,
  • improved intestinal barrier integrity,
  • boosted immunity,
  • better digestion and nutrient absorption,
  • reduction in the number of pathogenic microorganisms,
  • alleviation of symptoms in: IBS, SIBO, coeliac disease, IBD and many other conditions.
330 zł

60 capsules II This product is free from gluten, lactose, preservatives, anti-caking agents, flavourings and colourings.

 Dispatched within 24 hours

Poprzednia najniższa cena z ostatnich 30 dni: 330.00.

Description

MegaSporeBiotic™ is a probiotic containing 100% viable spores of probiotic bacteria from the Bacillus family, which have a broad spectrum of activity and clinically proven efficacy in maintaining the proper functioning of the intestinal barrier. 

beautiful-young-woman-with-vitiligo-1-scaled-aspect-ratio-875-673

How MegaSporeBiotic™ works

MegaSporeBiotic™ is formulated by combining highly resilient probiotic bacterial spores of the genus Bacillus, whose ability to maintain a healthy intestinal barrier and support overall immunity has been proven in clinical trials. The two-phase life cycle of Bacillus spores allows them to remain dormant in the harsh conditions of the human stomach and activate in the more favourable intestinal environment, where they begin colonisation and the process of intestinal repair. 

Published scientific studies demonstrate that the spores contained in Megasporebiotic reduce the amount of LPS endotoxin circulating in the blood, which causes chronic inflammation associated with many metabolic and cardiovascular diseases, as well as neurodegenerative conditions and depression.

The Bacillus strains contained in the product compete with pathogens and produce natural antibiotic substances that reduce the number of pathogenic microorganisms. They also produce a range of B vitamins essential for our health, as well as valuable antioxidants.

What makes this probiotic stand out?

  • the highest dose of probiotic bacterial spores available on the market,
  • exceptionally resistant to stomach acid and bile (99.99%),
  • binds to target sites in the gut and remains there for up to 3 weeks, driving metabolic processes beneficial to our health,
  • retains 100% efficacy during antibiotic therapy,
  • does not require refrigeration.

beautiful-young-woman-with-vitiligo-1-scaled-aspect-ratio-875-673

Additional information

a beautiful young woman with vitiligo

Adults and children aged 10 and over:

Week 1: 1 capsule every other day with a meal

Week 2: 1 capsule daily with a meal

Week 3 onwards: 2 capsules daily with a meal (take both capsules at the same time)

Maintenance dose: 2 capsules (taken together) with a meal twice a week

Children under 10 years of age:

Dosage to be determined by a therapist.

Do not exceed the recommended daily dose. This food supplement should not be used as a substitute for a varied diet and a healthy lifestyle.

Bacillus clausii (SC109), Bacillus subtilis (HU58), Bacillus coagulans (SC208), Bacillus licheniformis (SL307). Coating: cellulose, water.

The product contains 5 billion CFU of probiotic bacteria.

Manufactured in the USA.

Symptoms such as abdominal cramps, loose stools and noticeable bowel movements are unpleasant, but they are also a sign that the product is working and should subside within 2–3 days. If they persist, you should stop taking the supplement for a few days and then resume at a lower dose.

Pregnant and breastfeeding women should consult their therapist or doctor before taking this supplement.

The product can be safely stored at room temperature. The expiry date is printed on the packaging.

The pack contains 60 capsules.

Customer reviews

There are no reviews yet.

Research

Marzorati M, Bubeck S, Bayne T, Krishnan K, Giusto M.

Effects of combined prebiotic, probiotic, IgG and amino acid supplementation on the gut microbiome of patients with inflammatory bowel disease.

Źródło: Future Microbiol. November 2022;17:1307–1324. doi: 10.2217/fmb-2022-0066. Published online 16 September 2022. PMID: 36111808.
MCFARLIN BK, HENNING AL, CARBAJAL KM.

Oral spore-based probiotic supplementation was associated with a reduced incidence of postprandial dietary endotoxins, triglycerides and biomarkers of disease risk.

Źródło: World Journal of Gastrointestinal Pathophysiology. 15 August 2017; 8(3): 117–126
RHEE KJ, SETHUPATHI P, DRIKS A, et al.

The role of commensal bacteria in the development of gut-associated lymphoid tissue and the preimmune antibody repertoire.

Źródło: J Immunol. 2004;172(2):1118–24.
DE PUNDER K, PRUIMBOOM L.

Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability.

Źródło: Front Immunol. 2015;15(6):223.
GONG Y, LI H, LI Y.

The effects of Bacillus subtilis on epithelial tight junctions in mice with inflammatory bowel disease.

Źródło: J Interferon Cytokine Res. 2016;36(2).
SAMANYA M, YAMAUCHI K.

Histological changes in the intestinal villi of chickens fed dried Bacillus subtilis var. natto.

Źródło: Comp Biochem Physiol A Mol Integr Physiol. 2002;133(1):95–104.
TAM NKM, UYEN NQ, HONG HA, et al.

The Intestinal Life Cycle of Bacillus subtilis and Its Close Relatives.

Źródło: Journal of Bacteriology. 2006;188(7):2692–2700.
Marzorati M, Bubeck S, Bayne T, Krishnan K, Giusto M.

Effects of combined prebiotic, probiotic, IgG and amino acid supplementation on the gut microbiome of patients with inflammatory bowel disease.

Źródło: Future Microbiol. November 2022;17:1307–1324. doi: 10.2217/fmb-2022-0066. Published online 16 September 2022. PMID: 36111808.
MCFARLIN BK, HENNING AL, CARBAJAL KM.

Oral spore-based probiotic supplementation was associated with a reduced incidence of postprandial dietary endotoxins, triglycerides and biomarkers of disease risk.

Źródło: World Journal of Gastrointestinal Pathophysiology. 15 August 2017; 8(3): 117–126
RHEE KJ, SETHUPATHI P, DRIKS A, et al.

The role of commensal bacteria in the development of gut-associated lymphoid tissue and the preimmune antibody repertoire.

Źródło: J Immunol. 2004;172(2):1118–24.
DE PUNDER K, PRUIMBOOM L.

Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability.

Źródło: Front Immunol. 2015;15(6):223.
GONG Y, LI H, LI Y.

The effects of Bacillus subtilis on epithelial tight junctions in mice with inflammatory bowel disease.

Źródło: J Interferon Cytokine Res. 2016;36(2).
SAMANYA M, YAMAUCHI K.

Histological changes in the intestinal villi of chickens fed dried Bacillus subtilis var. natto.

Źródło: Comp Biochem Physiol A Mol Integr Physiol. 2002;133(1):95–104.
TAM NKM, UYEN NQ, HONG HA, et al.

The Intestinal Life Cycle of Bacillus subtilis and Its Close Relatives.

Źródło: Journal of Bacteriology. 2006;188(7):2692–2700.
front-view-female-scientist-analysing-potion-vials_23-2148571327

Customer questions (0)

There are no questions about this product yet. Log in to ask a question.